Clinical Trial Update: B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

View source ↗

Summary

This clinical trial update concerns a NIAID-sponsored study of B-lymphocyte immunotherapy in islet transplantation for initial islet graft failure. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• B-Lymphocyte Immunotherapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus | Status: NO_LONGER_AVAILABLE